Skip to main content

Want a detailed portfolio tracker?

OKYO Pharma Ltd - New (OKYO) P/E (2022 - 2026)

OKYO Pharma Ltd - New (OKYO) P/E from May 17, 2022 to Jul 20, 2026. The TTM OKYO Pharma Ltd - New (OKYO) P/E is -14.73. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of OKYO Pharma Ltd - New (OKYO)

YearP/EChange
2026-14.73-33.82%
2025-22.25-99.26%
2024-3.02K-19.78%
2023-3.77K+346.39%
2022-843.53N/A

Comparison OKYO Pharma Ltd - New (OKYO) P/E with competitors

OKYO Pharma Ltd - New (OKYO) P/E is -14.73.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.51%
FGENFibroGen Inc0.24-101.63%
CHRSCoherus Biosciences Inc0.85-105.76%
FBIOFortress Biotech Inc0.95-106.44%
ORMPOramed Pharmaceuticals Inc1.50-110.21%
AGENAgenus Inc3.01-120.44%
INVAInnoviva Inc3.15-121.42%
VXRTVaxart Inc3.55-124.10%
CRMDCorMedix Inc3.63-124.64%
CVACCureVac N.V.4.45-130.19%
GLPGGalapagos NV4.86-132.99%
SRPTSarepta Therapeutics Inc4.88-133.15%
ABEOAbeona Therapeutics Inc5.39-136.58%
ABUSArbutus Biopharma Corp5.60-137.99%
ZVRAZevra Therapeutics Inc5.89-139.97%
SPROSpero Therapeutics Inc6.23-142.29%
CGENCompugen Ltd6.31-142.87%
RIGLRigel Pharmaceuticals6.87-146.66%
SLXNSilexion Therapeutics Corp7.30-149.54%
OMEROmeros Corporation9.26-162.87%
AUPHAurinia Pharmaceuticals Inc9.58-165.08%
PLXProtalix BioTherapeutics Inc10.89-173.95%
ACADAcadia Pharmaceuticals Inc11.73-179.64%
TBPHTheravance Biopharma Inc12.26-183.26%
ADMAAdma Biologics Inc12.42-184.32%
HRMYHarmony Biosciences Holdings Inc13.82-193.84%
SABSSAB Biotherapeutics Inc14.14-195.99%
NAGENiagen Bioscience Inc14.82-200.62%
INCYIncyte Corp15.82-207.44%
REGNRegeneron Pharmaceuticals Inc15.86-207.67%
PBYIPuma Biotechnology Inc17.32-217.58%
CPRXCatalyst Pharmaceuticals Inc17.44-218.41%
EXELExelixis Inc17.54-219.08%
TGTXTG Therapeutics Inc18.97-228.78%
MDXGMimedx Group Inc20.55-239.55%
XOMAXOMA Royalty Corp22.87-255.33%
ARGXArgen X SE24.30-264.99%
CTMXCytomX Therapeutics Inc24.82-268.54%
XOMAOXOMA Royalty Corp25.34-272.10%
HALOHalozyme Therapeutics Inc25.62-273.99%
XOMAPXOMA Royalty Corp25.67-274.31%
VRTXVertex Pharmaceuticals Inc27.99-290.09%
RPRXRoyalty Pharma plc - Class A28.69-294.80%
SLNOSoleno Therapeutics Inc29.02-297.02%
ASNDAscendis Pharma A/S30.09-304.29%
LGNDLigand Pharmaceuticals Inc - Class B37.91-357.43%
APLSApellis Pharmaceuticals Inc39.02-364.97%
BMRNBiomarin Pharmaceutical Inc42.21-386.63%
KRYSKrystal Biotech Inc45.34-407.90%
ONCBeiGene Ltd69.54-572.20%
PHARPharming Group N.V.75.03-609.45%
TECHBio-Techne Corp101.96-792.33%
VCELVericel Corp109.92-846.40%
ALNYAlnylam Pharmaceuticals Inc117.96-901.02%
GMABGenmab140.29-1052.61%
TLXTelix Pharmaceuticals Ltd162.15-1201.06%
CORTCorcept Therapeutics Inc212.86-1545.36%